Literature DB >> 23193848

Bullous lung disease and neurofibromatosis type-1.

E Nardecchia1, L Perfetti, M Castiglioni, D Di Natale, A Imperatori, N Rotolo.   

Abstract

Lung interstitial diseases and bullae are described as possible complications of neurofibromatosis type-1 (NF-1), a genetic disorder inherited as a autosomal-dominant trait. We report the case of a 16-year-old male non-smoker with NF-1, who presented with pneumothorax caused by ruptured lung bullae. The case of this young patient, successfully treated by video-assisted thoracoscopic resection of bullae, supports the concept that pulmonary alterations may be part of the NF-1 syndrome, rather than as an unrelated complication.

Entities:  

Mesh:

Year:  2012        PMID: 23193848     DOI: 10.4081/monaldi.2012.159

Source DB:  PubMed          Journal:  Monaldi Arch Chest Dis        ISSN: 1122-0643


  5 in total

1.  Diffuse lung disease associated with neurofibromatosis type-1 can also affect children.

Authors:  Paolo Spinnato; Giancarlo Facchini; Alberto Bazzocchi; Ugo Albisinni
Journal:  World J Pediatr       Date:  2018-03-07       Impact factor: 2.764

2.  Interstitial lung disease and pre-capillary pulmonary hypertension in neurofibromatosis type 1.

Authors:  Daniela Rodrigues; Hugo Oliveira; Carina Andrade; Luísa Carvalho; Susana Guimarães; Conceição Souto Moura; Ana Paula Vaz
Journal:  Respir Med Case Rep       Date:  2018-03-17

3.  Spontaneous pneumothorax as a clinical manifestation of neurofibromatosis type 1.

Authors:  Tine Lorentzen; Hanne Madsen; Marie Josée Zareh Lausten-Thomsen; Anette Bygum
Journal:  BMJ Case Rep       Date:  2021-03-18

4.  Neurofibromatosis type 1: evaluation by chest computed tomography.

Authors:  Sérgio Ferreira Alves Júnior; Klaus Loureiro Irion; Alessandro Severo Alves de Melo; Gustavo de Souza Portes Meirelles; Rosana Souza Rodrigues; Arthur Soares Souza; Bruno Hochhegger; Gláucia Zanetti; Edson Marchiori
Journal:  Radiol Bras       Date:  2021 Nov-Dec

Review 5.  Current Understanding of Neurofibromatosis Type 1, 2, and Schwannomatosis.

Authors:  Ryota Tamura
Journal:  Int J Mol Sci       Date:  2021-05-29       Impact factor: 5.923

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.